These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

100 related articles for article (PubMed ID: 9167190)

  • 1. Frequent inactivation of the transforming growth factor beta type II receptor in small-cell lung carcinoma cells.
    de Jonge RR; Garrigue-Antar L; Vellucci VF; Reiss M
    Oncol Res; 1997; 9(2):89-98. PubMed ID: 9167190
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Inactivation of the transforming growth factor beta type II receptor in human small cell lung cancer cell lines.
    Hougaard S; Nørgaard P; Abrahamsen N; Moses HL; Spang-Thomsen M; Skovgaard Poulsen H
    Br J Cancer; 1999 Mar; 79(7-8):1005-11. PubMed ID: 10098728
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Heterogeneous transforming growth factor (TGF)-beta unresponsiveness and loss of TGF-beta receptor type II expression caused by histone deacetylation in lung cancer cell lines.
    Osada H; Tatematsu Y; Masuda A; Saito T; Sugiyama M; Yanagisawa K; Takahashi T
    Cancer Res; 2001 Nov; 61(22):8331-9. PubMed ID: 11719467
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Expression of transforming growth factor beta ligand and receptor messenger RNAs in lung cancer cell lines.
    Jakowlew SB; Mathias A; Chung P; Moody TW
    Cell Growth Differ; 1995 Apr; 6(4):465-76. PubMed ID: 7794814
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Abnormalities in expression of genes, mRNA, and proteins of transforming growth factor-beta receptor type I and type II in human pituitary adenomas.
    Fujiwara K; Ikeda H; Yoshimoto T
    Clin Neuropathol; 1998; 17(1):19-26. PubMed ID: 9496536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sequence-specific enhancer binding protein is responsible for the differential expression of ERT/ESX/ELF-3/ESE-1/jen gene in human gastric cancer cell lines: Implication for the loss of TGF-beta type II receptor expression.
    Park SH; Kim YS; Park BK; Hougaard S; Kim SJ
    Oncogene; 2001 Mar; 20(10):1235-45. PubMed ID: 11313868
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Loss of transforming growth factor-beta type II receptor gene expression in primary human esophageal cancer.
    Garrigue-Antar L; Souza RF; Vellucci VF; Meltzer SJ; Reiss M
    Lab Invest; 1996 Aug; 75(2):263-72. PubMed ID: 8765326
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor-beta receptors in human cancer cell lines: analysis of transcript, protein and proliferation.
    Jakowlew SB; Moody TW; Mariano JM
    Anticancer Res; 1997; 17(3C):1849-60. PubMed ID: 9216635
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Overexpression of transforming growth factor (TGF) beta1 type II receptor restores TGF-beta1 sensitivity and signaling in human prostate cancer cells.
    Guo Y; Kyprianou N
    Cell Growth Differ; 1998 Feb; 9(2):185-93. PubMed ID: 9486855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor beta signaling is disabled early in human endometrial carcinogenesis concomitant with loss of growth inhibition.
    Parekh TV; Gama P; Wen X; Demopoulos R; Munger JS; Carcangiu ML; Reiss M; Gold LI
    Cancer Res; 2002 May; 62(10):2778-90. PubMed ID: 12019154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Aberrant expression and mutations of TGF-beta receptor type II gene in endometrial cancer.
    Sakaguchi J; Kyo S; Kanaya T; Maida Y; Hashimoto M; Nakamura M; Yamada K; Inoue M
    Gynecol Oncol; 2005 Sep; 98(3):427-33. PubMed ID: 15993480
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of the human transforming growth factor beta type II receptor gene promoter by novel Sp1 sites.
    Jennings R; Alsarraj M; Wright KL; Muñoz-Antonia T
    Oncogene; 2001 Oct; 20(47):6899-909. PubMed ID: 11687969
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Decreased stability of transforming growth factor beta type II receptor mRNA in RER+ human colon carcinoma cells.
    Jiang W; Tillekeratne MP; Brattain MG; Banerji SS
    Biochemistry; 1997 Dec; 36(48):14786-93. PubMed ID: 9402753
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histone modification in the TGFbetaRII gene promoter and its significance for responsiveness to HDAC inhibitor in lung cancer cell lines.
    Osada H; Tatematsu Y; Sugito N; Horio Y; Takahashi T
    Mol Carcinog; 2005 Dec; 44(4):233-41. PubMed ID: 16163707
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential expression of transforming growth factor beta receptors in human pancreatic adenocarcinoma.
    Venkatasubbarao K; Ahmed MM; Mohiuddin M; Swiderski C; Lee E; Gower WR; Salhab KF; McGrath P; Strodel W; Freeman JW
    Anticancer Res; 2000; 20(1A):43-51. PubMed ID: 10769633
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Transcriptional repression of the transforming growth factor-beta type I receptor gene by DNA methylation results in the development of TGF-beta resistance in human gastric cancer.
    Kang SH; Bang YJ; Im YH; Yang HK; Lee DA; Lee HY; Lee HS; Kim NK; Kim SJ
    Oncogene; 1999 Dec; 18(51):7280-6. PubMed ID: 10602482
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Lack of transforming growth factor-beta type II receptor expression in human retinoblastoma cells.
    Horie K; Yamashita H; Mogi A; Takenoshita S; Miyazono K
    J Cell Physiol; 1998 Jun; 175(3):305-13. PubMed ID: 9572475
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Mechanism of resistance to growth inhibition by transforming growth factor-beta 1 (TGF-beta 1) in primary lung cancer and new molecular targets in therapy].
    Gemma A; Uematsu K; Hagiwara K; Takenoshita S; Kudoh S
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1253-9. PubMed ID: 10945024
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The expression of DNA methyltransferases and methyl-CpG-binding proteins is not associated with the methylation status of p14(ARF), p16(INK4a) and RASSF1A in human lung cancer cell lines.
    Sato M; Horio Y; Sekido Y; Minna JD; Shimokata K; Hasegawa Y
    Oncogene; 2002 Jul; 21(31):4822-9. PubMed ID: 12101420
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduced transcription of the RB2/p130 gene in human lung cancer.
    Xue Jun H; Gemma A; Hosoya Y; Matsuda K; Nara M; Hosomi Y; Okano T; Kurimoto F; Seike M; Takenaka K; Yoshimura A; Toyota M; Kudoh S
    Mol Carcinog; 2003 Nov; 38(3):124-9. PubMed ID: 14587097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.